Equity Profile

TMO

Thermo Fisher Scientific Inc.

Health CareLife Sciences Tools & Services$175.7B

Jul22Wed

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Thermo Fisher Scientific Inc. is a leading company in the health care sector, specializing in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

TMO Q2-2026 Earnings Preview

Context

Company Snapshot

Thermo Fisher Scientific Inc. is a leading company in the health care sector, specializing in life sciences tools and services. They provide essential products and services that support scientific research and laboratory work, which are critical for advancements in healthcare and pharmaceuticals.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+3.04%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, Thermo Fisher reported an EPS of $5.44, exceeding estimates by 4.68%. However, the stock fell 9.20% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Focus on innovation in life sciences tools.
Commitment to enhancing customer service and support.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Overall, investors are cautious ahead of the earnings report, especially given the recent stock decline despite positive earnings surprises.

Bull Case

If Thermo Fisher continues its trend of beating EPS estimates, it could signal strong operational performance and market confidence, potentially driving the stock higher.

Bear Case

Concerns about revenue growth and market conditions could lead to a negative reaction if the company fails to meet expectations, especially after recent stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

What are the revenue growth projections for the upcoming quarters?

Investors will be keen to understand the company's growth trajectory and whether it can maintain momentum in a competitive market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth due to new product launches and market expansion efforts.

Supporting Evidence

Thermo Fisher has consistently beaten EPS estimates, indicating stronger-than-expected performance.

The company has a solid track record of innovation, which could drive future growth.

Options pricing suggests a higher volatility expectation than historical averages, indicating potential for significant movement.

Key Risk

If revenue growth exceeds expectations due to successful new product launches, it could shift market sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the company's ability to sustain growth against potential economic headwinds, making these thresholds critical.

Bull Confirmed If

An EPS of $5.60 or higher would confirm strong operational performance and market confidence.

Bear Confirmed If

An EPS below $5.20 could raise concerns about the company's growth prospects and lead to a further decline in stock price.

Pre-Earnings Positioning

Options Market

Implied Move

±14.5%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±14.5% while TMO has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.3%

Calls (221K)P/C Ratio: 0.37Puts (485K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Thermo Fisher beats expectations, history suggests the stock could rise by around 0.93% on the first day, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance from management.

Miss

A miss could lead to a significant drop, potentially around 4.48% based on historical patterns, as concerns about growth resurface.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on new product launches and their expected impact on revenue.
2Any updates on market expansion strategies, particularly in emerging markets.
3Management's outlook on industry trends and competitive landscape.
4Insights into customer demand and feedback on existing products.
5Guidance on operational efficiencies and cost management strategies.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Domino's Pizza, Inc.

Company Snapshot

Thermo Fisher Scientific Inc. is a leading company in the health care sector, specializing in life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its business and capture market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

TMO Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+3.04%

Avg Stock Reaction

+0.93%

Last Quarter Recap

In Q1-2026, Thermo Fisher reported an EPS of $5.44, exceeding estimates by 4.68%. However, the stock fell 9.20% the following day, indicating market concerns despite the earnings beat.

Management Promises & Guidance

Focus on innovation in life sciences tools.
Commitment to enhancing customer service and support.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Overall, investors are cautious ahead of the earnings report, especially given the recent stock decline despite positive earnings surprises.

Bull Case

If Thermo Fisher continues its trend of beating EPS estimates, it could signal strong operational performance and market confidence, potentially driving the stock higher.

Bear Case

Concerns about revenue growth and market conditions could lead to a negative reaction if the company fails to meet expectations, especially after recent stock declines.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter, and how does it compare to previous quarters?

Given the company's history of beating EPS estimates, this figure will be crucial in determining market sentiment and stock performance.

What are the revenue growth projections for the upcoming quarters?

Investors will be keen to understand the company's growth trajectory and whether it can maintain momentum in a competitive market.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth due to new product launches and market expansion efforts.

Supporting Evidence

Thermo Fisher has consistently beaten EPS estimates, indicating stronger-than-expected performance.

The company has a solid track record of innovation, which could drive future growth.

Options pricing suggests a higher volatility expectation than historical averages, indicating potential for significant movement.

Key Risk

If revenue growth exceeds expectations due to successful new product launches, it could shift market sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is weighing the company's ability to sustain growth against potential economic headwinds, making these thresholds critical.

Bull Confirmed If

An EPS of $5.60 or higher would confirm strong operational performance and market confidence.

Bear Confirmed If

An EPS below $5.20 could raise concerns about the company's growth prospects and lead to a further decline in stock price.

Pre-Earnings Positioning

Options Market

Implied Move

±14.5%

Historical Avg

±4.5%

Pricing rich

The options market is pricing in a significant potential move, suggesting that investors expect volatility around the earnings announcement.

Options are pricing ±14.5% while TMO has averaged ±4.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

41.3%

Calls (221K)P/C Ratio: 0.37Puts (485K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Thermo Fisher beats expectations, history suggests the stock could rise by around 0.93% on the first day, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance from management.

Miss

A miss could lead to a significant drop, potentially around 4.48% based on historical patterns, as concerns about growth resurface.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on new product launches and their expected impact on revenue.
2Any updates on market expansion strategies, particularly in emerging markets.
3Management's outlook on industry trends and competitive landscape.
4Insights into customer demand and feedback on existing products.
5Guidance on operational efficiencies and cost management strategies.